19 studies found for:    Open Studies | "Anus Diseases"
Show Display Options
Rank Status Study
1 Unknown  Comparison of Biofeedback vs. Botox Injection to Treat Levator Ani Syndrome
Condition: Levator Ani Syndrome With Pain and/or Constipation Symptoms.
Interventions: Behavioral: Biofeedback therapy;   Procedure: Botulinum Toxin Type A Injection
2 Recruiting Vorinostat in Combination With Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
Conditions: HIV Infection;   Recurrent Anal Cancer;   Recurrent Breast Cancer;   Recurrent Esophageal Cancer;   Recurrent Gastric Cancer;   Recurrent Metastatic Squamous Neck Cancer With Occult Primary;   Recurrent Non-small Cell Lung Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Salivary Gland Cancer;   Recurrent Squamous Cell Carcinoma of the Hypopharynx;   Recurrent Squamous Cell Carcinoma of the Larynx;   Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity;   Recurrent Squamous Cell Carcinoma of the Nasopharynx;   Recurrent Squamous Cell Carcinoma of the Oropharynx;   Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Recurrent Verrucous Carcinoma of the Larynx;   Recurrent Verrucous Carcinoma of the Oral Cavity;   Salivary Gland Squamous Cell Carcinoma;   Stage IV Anal Cancer;   Stage IV Breast Cancer;   Stage IV Esophageal Cancer;   Stage IV Gastric Cancer;   Stage IV Non-small Cell Lung Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IV Salivary Gland Cancer;   Stage IV Squamous Cell Carcinoma of the Hypopharynx;   Stage IV Squamous Cell Carcinoma of the Larynx;   Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IV Squamous Cell Carcinoma of the Nasopharynx;   Stage IV Squamous Cell Carcinoma of the Oropharynx;   Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IV Verrucous Carcinoma of the Larynx;   Stage IV Verrucous Carcinoma of the Oral Cavity;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: vorinostat;   Other: diagnostic laboratory biomarker analysis;   Other: pharmacological study;   Drug: carboplatin;   Drug: paclitaxel
3 Recruiting Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer
Condition: Anal Cancer
Interventions: Drug: Tempol;   Drug: 5-Fluorouracil;   Drug: Mitomycin-C;   Procedure: Radiation Therapy
4 Recruiting Radiochemotherapy With Panitumumab in the Localised Epidermoid Carcinoma of the Anus
Conditions: Epidermoid Carcinoma;   Anus
Interventions: Drug: radiochemotherapy;   Drug: Panitumumab
5 Unknown  Predictive Value of FMISO-PET, FDG-PET-CT, DWI-MRI and DCE-MRI Scans for Patients With Anal Cancer Receiving Radiotherapy +/- Chemotherapy
Condition: Anal Cancer
Intervention: Other: FMISO-PET, FDG-PET-CT and Magnetic Resonance Imaging (MRI)
6 Recruiting Anal Cancer Radiotherapy Study
Condition: Anal Cancer
Intervention:
7 Recruiting Dose Escalation Trial of Endoluminal High-Dose-Rate Brachytherapy With Concurrent Chemotherapy for Rectal or Anal Cancer in Patients With Recurrent Disease or Undergoing Non-Operative Management
Condition: Rectal or Anal Cancer
Interventions: Radiation: endorectal brachytherapy;   Drug: concurrent capecitabine or 5-FU;   Behavioral: Questionnaires
8 Recruiting Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions
Conditions: Anal Cancer;   High-grade Squamous Intraepithelial Lesion;   HIV Infection;   Human Papilloma Virus Infection
Interventions: Drug: imiquimod;   Drug: fluorouracil;   Procedure: infrared photocoagulation therapy;   Procedure: thermal ablation therapy;   Procedure: laser therapy;   Other: clinical observation;   Other: laboratory biomarker analysis;   Procedure: quality-of-life assessment
9 Recruiting An Open Label Multi-Dose Study to Examine the Effect of Coated Nifedipine Suppository on Anal Fissure Pain and Healing
Condition: Anal Fissure
Intervention: Drug: Nifedipine 12 mg coated suppositories
10 Recruiting Effects of Deep Regional Hyperthermia in Patients With Anal Carcinoma Treated by Standard Radiochemotherapy
Condition: Anal Carcinoma
Interventions: Radiation: Irradiation;   Drug: Mitomycin C;   Drug: 5-Fluorouracil;   Procedure: Hyperthermia
11 Not yet recruiting Functional Outcomes Following Anal Cancer Treatment
Condition: Anal Cancer
Intervention:
12 Unknown  Low-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal Cancer
Conditions: Anal Cancer;   Bladder Cancer;   Cervical Cancer;   Colorectal Cancer;   Fallopian Tube Cancer;   Gastrointestinal Complications;   Ovarian Cancer;   Radiation Toxicity;   Sarcoma
Interventions: Dietary Supplement: dietary intervention;   Other: laboratory biomarker analysis;   Procedure: gastrointestinal complications management/prevention;   Procedure: management of therapy complications;   Radiation: selective external radiation therapy
13 Recruiting International Multicentre Study in Advanced Anal Cancer Comparing Cisplatin Plus 5 FU vs Carboplatin Plus Weekly Paclitaxel
Condition: Squamous Cell Carcinoma of the Anus
Interventions: Drug: Cisplatin;   Drug: 5-Fluorouracil (5-FU);   Drug: Carboplatin;   Drug: Paclitaxel
14 Recruiting A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer
Condition: Anal Cancer
Intervention: Biological: Advaxis
15 Recruiting Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Anal Cancer
Condition: Anal Cancer
Interventions: Biological: cetuximab;   Drug: cisplatin;   Drug: fluorouracil;   Radiation: radiation therapy
16 Recruiting Treatment Of Chronic Anal Fissure
Condition: Chronic Anal Fissure
Interventions: Other: Levorag Emulgel;   Drug: Diltiazem
17 Not yet recruiting PHASE 2 STUDY OF ADXS11-001 IN SUBJECTS WITH ANAL CANCER OR CANCER OF THE RECTUM
Conditions: Anal Cancer;   Rectal Cancer
Intervention: Drug: ADXS11-001
18 Recruiting Pharmacokinetic,Safety and Exploratory Efficacy of RECTIV® in Adolescents With Chronic Anal Fissure
Condition: Anal Fissure
Intervention: Drug: Nitroglycerin Ointment 0.4%
19 Unknown  Treatment of Anal Fissure by Activated Human Macrophages
Conditions: Biological Therapy for Chronic Anal Fissure;   Treatment by Biological Factors - Activated Macrophages;   Interventional Study
Intervention: Drug: Local injection of activated macrophages to anal fissure

Indicates status has not been verified in more than two years